USA Finasteride Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Finasteride Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Type I Market Performance (Volume)
  • 2.1.2 Type II Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Type I Market Performance (Value)
  • 2.1.2 Type II Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Benign Prostatic Hyperplasia Market Performance (Volume)
  • 3.1.2 Male Pattern Baldness Market Performance (Volume)
  • 3.1.3 Other Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Merck
  • 4.1.1 Merck Profiles
  • 4.1.2 Merck Product Information
  • 4.1.3 Merck Finasteride Business Performance
  • 4.1.4 Merck Finasteride Business Development and Market Status
• 4.2 Actavis
  • 4.2.1 Actavis Profiles
  • 4.2.2 Actavis Product Information
  • 4.2.3 Actavis Finasteride Business Performance
  • 4.2.4 Actavis Finasteride Business Development and Market Status
• 4.3 Sandoz
  • 4.3.1 Sandoz Profiles
  • 4.3.2 Sandoz Product Information
  • 4.3.3 Sandoz Finasteride Business Performance
  • 4.3.4 Sandoz Finasteride Business Development and Market Status
• 4.4 Teva Pharmaceuticals
  • 4.4.1 Teva Pharmaceuticals Profiles
  • 4.4.2 Teva Pharmaceuticals Product Information
  • 4.4.3 Teva Pharmaceuticals Finasteride Business Performance
  • 4.4.4 Teva Pharmaceuticals Finasteride Business Development and Market Status
• 4.5 Cipla
  • 4.5.1 Cipla Profiles
  • 4.5.2 Cipla Product Information
  • 4.5.3 Cipla Finasteride Business Performance
  • 4.5.4 Cipla Finasteride Business Development and Market Status
• 4.6 RelonChem
  • 4.6.1 RelonChem Profiles
  • 4.6.2 RelonChem Product Information
  • 4.6.3 RelonChem Finasteride Business Performance
  • 4.6.4 RelonChem Finasteride Business Development and Market Status
• 4.7 Dr. Reddy
  • 4.7.1 Dr. Reddy Profiles
  • 4.7.2 Dr. Reddy Product Information
  • 4.7.3 Dr. Reddy Finasteride Business Performance
  • 4.7.4 Dr. Reddy Finasteride Business Development and Market Status
• 4.8 Accord Pharmaceuticals
  • 4.8.1 Accord Pharmaceuticals Profiles
  • 4.8.2 Accord Pharmaceuticals Product Information
  • 4.8.3 Accord Pharmaceuticals Finasteride Business Performance
  • 4.8.4 Accord Pharmaceuticals Finasteride Business Development and Market Status
• 4.9 Henan Topfond
  • 4.9.1 Henan Topfond Profiles
  • 4.9.2 Henan Topfond Product Information
  • 4.9.3 Henan Topfond Finasteride Business Performance
  • 4.9.4 Henan Topfond Finasteride Business Development and Market Status
• 4.10 Zhejiang CONBA Pharmaceutical
  • 4.10.1 Zhejiang CONBA Pharmaceutical Profiles
  • 4.10.2 Zhejiang CONBA Pharmaceutical Product Information
  • 4.10.3 Zhejiang CONBA Pharmaceutical Finasteride Business Performance
  • 4.10.4 Zhejiang CONBA Pharmaceutical Finasteride Business Development and Market Status
• 4.11 Shandong Renhetang Pharmaceutical
• 4.12 Guangdong Eashu Pharmacetical

5 Market Performance for Manufacturers

• 5.1 USA Finasteride Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 USA Finasteride Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 USA Finasteride Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 USA Finasteride Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Northeast Market Performance for Manufacturers
  • 6.1.1 Northeast Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Northeast Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Northeast Finasteride Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Northeast Finasteride Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 Midwest Market Performance for Manufacturers
  • 6.2.1 Midwest Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 Midwest Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 Midwest Finasteride Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 Midwest Finasteride Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 South Market Performance for Manufacturers
  • 6.3.1 South Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 South Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 South Finasteride Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 South Finasteride Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 West Market Performance for Manufacturers
  • 6.4.1 West Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 West Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 West Finasteride Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 West Finasteride Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration

7 USA Finasteride Market Performance (Sales Point)

• 7.1 USA Finasteride Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 USA Finasteride Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 USA Finasteride Price (USD/Unit) by Regions 2013-2018
• 7.4 USA Finasteride Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 USA Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Northeast Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 Midwest Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 South Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 West Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Benign Prostatic Hyperplasia Industry
• 11.2 Male Pattern Baldness Industry
• 11.3 Other Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 USA Finasteride Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 USA Finasteride Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Northeast Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 Midwest Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 South Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 West Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Benign Prostatic Hyperplasia Sales and and Growth Rate 2019-2024
  • 12.4.3 Male Pattern Baldness Sales and and Growth Rate 2019-2024
  • 12.4.4 Other Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 USA Finasteride Price (USD/Unit) Trend 2019-2024
  • 12.5.2 USA Finasteride Gross Profit Trend 2019-2024

13 Conclusion